tiprankstipranks
Trending News
More News >
Aprea Therapeutics Inc (APRE)
NASDAQ:APRE
US Market

Aprea Therapeutics (APRE) Cash flow

Compare
486 Followers

Aprea Therapeutics Cash Flow

APRE's free cash flow for Q3 2025 was $-3.26M. For the 2025 fiscal year, APRE's free cash flow was decreased by $-1.30M and operating cash flow was $-3.26M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -13.56M$ -12.18M$ -25.01M$ -37.69M$ -41.80M
Investing Cash Flow
$ -15.48K$ -93.09K$ 0.00$ 0.00$ -25.71K
Financing Cash Flow
$ 14.82M$ 5.14M$ 682.97K$ 1.75M$ 150.95K
End Cash Position
$ 22.89M$ 21.65M$ 28.79M$ 53.08M$ 89.02M
Free Cash Flow
$ -13.57M$ -12.27M$ -25.01M$ -37.69M$ -41.83M
Currency in USD

Aprea Therapeutics Cash Flow